July 9, 2013 – GBCHealth announced today its reappointment to a three-year term as the Focal Point for the Private Sector Constituency to the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria. GBCHealth has served in this role since 2006.
As Focal Point, GBCHealth orchestrates the Private Sector Delegation (PSD) to the Global Fund Board, and partners closely with the PSD Advisory Group, a committed group of companies that brings the business voice and business expertise to major Global Fund decisions on policy, strategy and governance. There are currently 17 members of the PSD Advisory Group: AbbVie, Abt Associates, Access Bank, Anglo American plc, BD, Bayer, Chevron, Eli Lilly, Gilead, Merck, Mylan, Novartis, Product (RED), SABMiller, Sanofi, Sumitomo Chemical and Vestergaard Frandsen.
GBCHealth began its new term in June at an important time in the Global Fund’s history. With the new leadership of Executive Director Dr. Mark Dybul, the Global Fund hopes to save 10 million lives and prevent 140-180 million new infections from HIV/AIDS, tuberculosis and malaria between 2012 and 2016.
GBCHealth will play a key role supporting the Private Sector Delegation’s work to increase private sector contributions to the Global Fund in the upcoming 4th replenishment and to strengthen private sector partnerships in countries that receive grants.
“GBCHealth’s deep knowledge, rich relationships and long-standing commitment to ending HIV/AIDS, malaria and tuberculosis make it the ideal organization to position the private sector as a top-tier partner to the Global Fund,” said Ray Chambers, Co-Chair of the GBCHealth Board of Directors. Chambers is the U.N. Secretary-General’s Special Envoy for Financing the Health Millennium Development Goals and for Malaria.
GBCHealth, formerly called the Global Business Coalition on HIV/AIDS Tuberculosis and Malaria, is a non-profit coalition of more than 200 companies working to improve the health of their workforces and communities around the world.
GBCHealth has served as the Focal Point since 2006 and has provided crucial policy support and coordination for the Private Sector Delegation on major Global Fund issues and decisions. These include the appointment of new Executive Directors, the implementation of a major 2011 governance reform agenda, and, most recently, the development of a new approach to grant-making that was launched earlier this year.
GBCHealth looks forward to working alongside companies to build on its accomplishments as Focal Point for the next three years.